VABYSMO is contraindicated in patients with ocular or periocular infections.
VABYSMO is contraindicated in patients with active intraocular inflammation.
VABYSMO is contraindicated in patients with known hypersensitivity to faricimab or any of the excipients. Hypersensitivity reactions may manifest as rash, pruritus, urticaria, erythema, or severe intraocular inflammation.
Sign Out